Skip to content

Clinical trials

Completed Waldenstrom Macroglobulinemia trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Waldenstrom Macroglobulinemia Status: Completed Country / region: Italy Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20011
20033
20041
20053
20111
20142
20161
20171
20181
20191
20211
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed21

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fred Hutchinson Cancer Center9
European Organisation for Research and Treatment of Cancer - EORTC3
Fondazione Italiana Linfomi - ETS2
ADC Therapeutics S.A.1
BeiGene1
Eli Lilly and Company1
Federico II University1
Gilead Sciences1
Loxo Oncology, Inc.1
Pharmacyclics LLC.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Waldenstrom Macroglobulinemia21
Leukemia, Lymphocytic, Chronic, B-Cell16
Lymphoma, Non-Hodgkin16
Lymphoma, Mantle-Cell14
Lymphoma, B-Cell, Marginal Zone13
Lymphoma, Follicular13
Multiple Myeloma13
Lymphoma, Large B-Cell, Diffuse12
Burkitt Lymphoma11
Hodgkin Disease11

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.